Inhibition of bacterial superantigens by peptides and antibodies

被引:57
作者
Visvanathan, K
Charles, A
Bannan, J
Pugach, P
Kashfi, K
Zabriskie, JB
机构
[1] Rockefeller Univ, Lab Clin Microbiol & Immunol, New York, NY 10021 USA
[2] Amer Type Culture Collect, Bacteriol Sect, Manassas, VA 20110 USA
[3] CUNY, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA
关键词
D O I
10.1128/IAI.69.2.875-884.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pyrogenic exotoxins of group A streptococci and staphylococcal enterotoxins are a family of structurally related superantigens with similar biological activity. Two distinct areas have been identified which have a highly conserved amino acid homology in all of the toxin families. A number of peptides were constructed from these regions, some of which were concatenated and polymerized to enhance their immunogenicity in animals. Antibodies prepared against these polymerized peptides were used to serologically identify the majority of the superantigen toxins, block the biological activities of the superantigens, and protect an experimental animal model against shock. In addition certain peptides were able per se to block up to 90% of the proliferative responses induced by the toxins. The peptide also proved protective in a septic shock model in mice. Binding experiments indicate that the peptide binds tightly to the major histocompatibility complex class II molecule, thus preventing binding and hence activation of the superantigen. The selective and rapid binding of the peptide to the major histocompatibility complex class II molecule may lead to a novel therapeutic modality in treatment of superantigen-mediated diseases.
引用
收藏
页码:875 / 884
页数:10
相关论文
共 24 条
  • [1] Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation
    Arad, G
    Levy, R
    Hillman, D
    Kaempfer, R
    [J]. NATURE MEDICINE, 2000, 6 (04) : 414 - 421
  • [2] Structure and function of streptococcal and staphylococcal superantigens in septic shock
    Bannan, J
    Visvanathan, K
    Zabriskie, JB
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1999, 13 (02) : 387 - +
  • [3] Bannan JD, 1997, ADV EXP MED BIOL, V418, P903
  • [4] Superantigen and endotoxin synergize in the induction of lethal shock
    Blank, C
    Luz, A
    Bendigs, S
    Erdmann, A
    Wagner, H
    Heeg, K
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) : 825 - 833
  • [5] Identification of domains involved in superantigenicity of streptococcal pyrogenic exotoxin F (SpeF)
    Eriksson, A
    Holm, SE
    Norgren, M
    [J]. MICROBIAL PATHOGENESIS, 1998, 25 (05) : 279 - 290
  • [6] Fridkis-Hareli M, 1998, J IMMUNOL, V160, P4386
  • [7] Treatment of endotoxic shock: Glucocorticoids, lazaroids, nonsteroidals, others
    Howe, LM
    [J]. VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1998, 28 (02) : 249 - +
  • [8] Hu DL, 1999, FEMS IMMUNOL MED MIC, V25, P237, DOI 10.1111/j.1574-695X.1999.tb01348.x
  • [9] HULL D, 1993, BIOL NEONATE, V63, P370
  • [10] 3-DIMENSIONAL STRUCTURE OF A HUMAN CLASS-II HISTOCOMPATIBILITY MOLECULE COMPLEXED WITH SUPERANTIGEN
    JARDETZKY, TS
    BROWN, JH
    GORGA, JC
    STERN, LJ
    URBAN, RG
    CHI, YI
    STAUFFACHER, C
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1994, 368 (6473) : 711 - 718